MoneyWorks4Me

Syngene International informs about update

23 Dec 2023 Evaluate

Syngene International has informed about update on the acquisition of biologics manufacturing facility from Stelis Biopharma. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sagility 44.22
Prime Focus 285.65
Knowledge RealtyTrt. 113.31
Indegene 594.55
Syngene Internatl. 388.40
View more..